--2025/Q2-- / 0.000--
--2025/Q1-- / 0.000--
--2024/Q40.000 / 0.000--
--2024/Q10.000 / 0.000--
--2023/Q40.000 / 0.000--
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
Lennar Corp
LEN
KB Home
KBH
US Stock MarketDetailed Quotes
GTBP GT Biopharma
- 2.2400
- +0.2100+10.34%
Trading Feb 25 12:46 ET
5.00MMarket Cap-0.32P/E (TTM)
3.1200High2.0200Low25.44MVolume2.4600Open2.0300Pre Close68.06MTurnover1584.86%Turnover RatioLossP/E (Static)2.23MShares10.659952wk High-2.99P/B3.60MFloat Cap1.720052wk Low--Dividend TTM1.61MShs Float591.9900Historical High--Div YieldTTM54.19%Amplitude1.7200Historical Low2.6750Avg Price1Lot Size
GT Biopharma Key Stats
GT Biopharma Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
GT Biopharma Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data